Article info

Download PDFPDF

A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

Authors

  1. Address correspondence and reprint requests to: Nicola Gebbia, MD, Operative Unit of Medical Oncology, Department of Oncology, Università degli Studi di Palermo, Via del Vespro 127, 90127 Palermo, Italy. Email: chemotherapy{at}inwind.it

Citation

Valerio MR, Tagliaferri P, Raspagliesi F, et al
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

Publication history

  • First published January 1, 2006.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.